Thiosalicylic acid

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Thiosalicylic acid
Accession Number
DB14026
Type
Small Molecule
Groups
Experimental
Description
Not Available
Structure
Thumb
Synonyms
  • 2-Carboxythiophenol
  • 2-Mercaptobenzoic acid
  • 2-Sulfanylbenzoic acid
  • 2-Thiosalicylic acid
  • o-Benzoic acid thiol
  • o-Carboxythiophenol
  • o-Mercaptobenzoic acid
  • o-Mercaptobenzösäure
  • o-Sulfhydrylbenzoic acid
  • o-Thiosalicylic acid
  • Thiophenol-2-carboxylic acid
  • Thiosalicylate
International/Other Brands
Pirosal / Thiocyl
Categories
UNII
CIP6LXN5XW
CAS number
147-93-3
Weight
Average: 154.186
Monoisotopic: 154.008850126
Chemical Formula
C7H6O2S
InChI Key
NBOMNTLFRHMDEZ-UHFFFAOYSA-N
InChI
InChI=1S/C7H6O2S/c8-7(9)5-3-1-2-4-6(5)10/h1-4,10H,(H,8,9)
IUPAC Name
2-sulfanylbenzoic acid
SMILES
OC(=O)C1=C(S)C=CC=C1

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
(R)-warfarinThiosalicylic acid may increase the anticoagulant activities of (R)-warfarin.
(S)-WarfarinThiosalicylic acid may increase the anticoagulant activities of (S)-Warfarin.
1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic AcidThe risk or severity of renal failure can be increased when Thiosalicylic acid is combined with 1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid.
2,4-thiazolidinedioneThiosalicylic acid may increase the hypoglycemic activities of 2,4-thiazolidinedione.
3,5-diiodothyropropionic acidThe therapeutic efficacy of 3,5-diiodothyropropionic acid can be increased when used in combination with Thiosalicylic acid.
4-hydroxycoumarinThiosalicylic acid may increase the anticoagulant activities of 4-hydroxycoumarin.
AbaloparatideThe therapeutic efficacy of Abaloparatide can be increased when used in combination with Thiosalicylic acid.
AbciximabThe risk or severity of bleeding can be increased when Thiosalicylic acid is combined with Abciximab.
AcarboseThiosalicylic acid may increase the hypoglycemic activities of Acarbose.
AceclofenacThe therapeutic efficacy of Thiosalicylic acid can be decreased when used in combination with Aceclofenac.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Evidence Level

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
KEGG Drug
D08586
ChemSpider
5248
ChEBI
59124
ChEMBL
CHEMBL119888
HET
JKE
Wikipedia
Thiosalicylic_acid
PDB Entries
3lk1 / 4e4a

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility1.7 mg/mLALOGPS
logP1.65ALOGPS
logP1.72ChemAxon
logS-2ALOGPS
pKa (Strongest Acidic)3.34ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area37.3 Å2ChemAxon
Rotatable Bond Count1ChemAxon
Refractivity41.32 m3·mol-1ChemAxon
Polarizability14.89 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Classification
Not classified

Drug created on May 15, 2018 10:51 / Updated on May 01, 2019 11:56